Intuitive Surgical, Inc. (ISRG)
Automate Your Wheel Strategy on ISRG
With Tiblio's Option Bot, you can configure your own wheel strategy including ISRG - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ISRG
- Rev/Share 24.3773
- Book/Share 48.1334
- PB 11.6144
- Debt/Equity 0.0
- CurrentRatio 4.9787
- ROIC 0.1236
- MktCap 199190803500.0
- FreeCF/Share 4.882
- PFCF 114.1298
- PE 80.2393
- Debt/Assets 0.0
- DivYield 0
- ROE 0.1552
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 3
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Intuitive Surgical, Inc. (ISRG) Laps the Stock Market: Here's Why
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Neutral
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $555.75, marking a +0.6% move from the previous day.
Read More
ISRG vs. MDT: Which Robotic Surgery Stock Is a Smarter Buy Now?
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Neutral
Intuitive Surgical or Medtronic -- who leads the future of robotic surgery? Here's a comparative analysis to help you make a smart choice for 2025.
Read More
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Read More
Intuitive Announces CEO Transition Effective July 1, 2025
Published: May 15, 2025 by: GlobeNewsWire
Sentiment: Neutral
President Dave Rosa promoted to CEO Current CEO Gary Guthart to become executive chair of Intuitive's board Current Board Chair Craig Barratt to become lead independent director
Read More
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Trade Tracker: Stephanie Link sells Eli Lilly and buys more Intuitive Surgical
Published: May 12, 2025 by: CNBC Television
Sentiment: Neutral
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio moves.
Read More
The Transformative Rise of Global Robotics: A 2025 Market Analysis
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Robotics is poised for robust growth in 2025. Watch NVDA, ISRG, SERV and PATH for potential market dominance across healthcare, manufacturing and mobility sectors.
Read More
2 Stocks I Can't Wait to Buy During the Next Market Correction
Published: May 06, 2025 by: The Motley Fool
Sentiment: Positive
Investors never know when the next market correction -- a drop of from 10% to 20% in an index -- is coming, but we know that it will eventually happen. And because that's true, it makes sense to make a list of the stocks you'd like to buy if they dip during a correction.
Read More
Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection
Published: May 01, 2025 by: GlobeNewsWire
Sentiment: Neutral
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared the da Vinci Single Port (SP) surgical system for transanal local excision/resection, a form of minimally invasive surgery performed through a natural orifice to avoid abdominal surgical incisions for select procedures. This clearance extends the da Vinci SP's capabilities in colorectal surgery, building upon procedures previously cleared by the FDA in November 2024, which include transabdominal procedures - low anterior resection, total mesorectal excision, …
Read More
Trump's Tariffs Could Impact This Top Growth Stock. Here's Why It's Still a Buy
Published: May 01, 2025 by: The Motley Fool
Sentiment: Negative
President Donald Trump's macroeconomic policies are creating significant uncertainty. His decision to impose sweeping tariffs on goods imported into the U.S. could harm the economy and specific corporations in ways that are scaring off investors.
Read More
Baron Health Care Fund Q1 2025 Top Contributors And Detractors
Published: April 29, 2025 by: Seeking Alpha
Sentiment: Positive
Boston Scientific's shares rose due to strong market growth, innovative products like pulsed field ablation, and disciplined cost management, driving double-digit EPS growth. Vertex Pharmaceuticals saw increased investor confidence in its cystic fibrosis franchise and evolving pipeline, including promising non-opioid pain treatments and kidney disease drugs. UnitedHealth Group's shares gained as 2024 headwinds subsided, Medicare Advantage rates improved, and higher-margin Optum segments grew, insulating it from tariff impacts.
Read More
2 Growth Stocks to Buy on the Dip if the Market Crashes Again
Published: April 26, 2025 by: The Motley Fool
Sentiment: Neutral
Anxious investors who picked April to go on a long internet-free vacation couldn't have planned it better. Earlier this month, the S&P 500 index quickly sank more than 10% after President Donald Trump unveiled tariff rules that threatened the U.S. economy.
Read More
ISRG Stock Falls Despite Q1 Earnings Beat, Gross Margin Contracts
Published: April 23, 2025 by: Zacks Investment Research
Sentiment: Negative
ISRG's first-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.
Read More
Final Trades: 3M, Abbvie, Salesforce and Intuitive Surgical
Published: April 22, 2025 by: CNBC Television
Sentiment: Neutral
The Investment Committee give you their top stocks to watch for the second half.
Read More
ISRG Q1 Earnings Coming Up: Time to Buy, Sell or Hold the Stock?
Published: April 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical's first-quarter results are likely to reflect solid performance in the company???s Instruments & Accessories segment.
Read More
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
Published: April 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Published: April 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Read More
New Research Explores Access to Minimally Invasive Care and the Impact of Robotic-Assisted Surgery
Published: April 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
Studies show robotic-assisted procedures enable increased access to minimally invasive care Studies show robotic-assisted procedures enable increased access to minimally invasive care
Read More
Intuitive Surgical, Inc. (ISRG) Reports Next Week: Wall Street Expects Earnings Growth
Published: April 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical (ISRG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Intuitive Surgical Shares May Rise as FDA Clears SureForm 45 Stapler
Published: April 14, 2025 by: Zacks Investment Research
Sentiment: Neutral
ISRG secures FDA clearance for the first stapler designed for single-port robotic surgery, advancing minimally invasive procedures and enhancing surgical precision.
Read More
Intuitive Surgical (ISRG) Moves 14.3% Higher: Will This Strength Last?
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical (ISRG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Read More
U.S. FDA clears first stapler designed for single-port robotic surgery
Published: April 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
Intuitive's SureForm 45 stapler available for thoracic, colorectal, and urology procedures Intuitive's SureForm 45 stapler available for thoracic, colorectal, and urology procedures
Read More
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
Published: April 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Read More
Will Intuitive Surgical (ISRG) Beat Estimates Again in Its Next Earnings Report?
Published: April 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
Published: March 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Prediction: These 2 Stocks Will Outperform the Market Through 2030
Published: March 18, 2025 by: The Motley Fool
Sentiment: Positive
Equity markets can move every which way from one day to the next. The more we extend our horizon, the more likely it is that stocks will provide juicy returns.
Read More
4 Leading Robotics Stocks to Watch Amid 2025 Automation Boom
Published: March 17, 2025 by: Zacks Investment Research
Sentiment: Positive
AI-powered robotics are set to soar in 2025. Key players like NVDA, ISRG, TSLA and PATH lead transformation across healthcare, manufacturing and mobility sectors.
Read More
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
Published: March 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Read More
About Intuitive Surgical, Inc. (ISRG)
- IPO Date 2000-06-16
- Website https://www.intuitive.com
- Industry Medical - Instruments & Supplies
- CEO Dr. Gary S. Guthart Ph.D.
- Employees 15638